Advanced Paternal Age Does Not Affect Medically-Relevant Obstetrical and Perinatal Outcomes following IVF or ICSI in Humans with Donated Oocytes.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Mossetti, Laura
  • Rivera-Egea, Rocio

Grupos

Abstract

BACKGROUND: Concomitant with delays in childbearing, concerns have been raised of whether advanced paternal age is associated with adverse reproductive outcomes, but the evidence is controversial in part due to the uncertain threshold in which to consider advanced paternal age and confounding maternal factors. This retrospective study aimed to evaluate the effect of paternal age on reproductive outcomes related to the pregnancy and perinatal health of the offspring. METHODS: We retrospectively evaluated 16,268 cases of patients who underwent IVF or ICSI (using autologous sperm and donated oocytes, between January 2008 and March 2020, at Spanish IVIRMA clinics. Patients were divided based on paternal age at conception [=30 (n = 204), 31-40 (n = 5752), and >40 years (n = 10,312)], and the differences in obstetrical and perinatal outcomes were analyzed by descriptive analysis, followed by univariate and multivariate analysis. RESULTS: Fathers 31-40 and >40 years old were associated with lower odds of caesarean delivery [AOR 0.63 (95% CI, 0.44-0.90; p = 0.012) and AOR 0.61 (95% CI, 0.41-0.91; p = 0.017), respectively] and longer pregnancies [ARC 5.09 (95% CI, 2.39-7.79; p < 0.001) and ARC 4.54 (95% CI, 1.51-7.58; p = 0.003), respectively] with respect to fathers =30 years old. Furthermore, fathers aged 31-40 years old had lower odds of having a female infant (AOR, 0.70; 95% CI, 0.49-0.99; p = 0.045) than those =30. The rest of obstetrical and perinatal outcomes, which we deemed more medically-relevant as they were considered serious for health, were comparable between groups with our adjusted model. CONCLUSIONS: Despite this hopeful message to fathers of advanced paternal age, future studies should consider the short- and long-term outcomes of the offspring and try to better elucidate the associations of advanced paternal age with reproductive outcomes and the molecular mechanisms underlying the observed associations.

Datos de la publicación

ISSN/ISSNe:
2077-0383, 2077-0383

Journal of clinical medicine  MDPI AG

Tipo:
Article
Páginas:
-
Factor de Impacto:
1,040 SCImago
Cuartil:
Q1 SCImago

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • assisted reproductive technology (ART); donated oocytes; obstetrical outcomes; offspring’s health; paternal age; perinatal outcomes; pregnancy

Campos de estudio

Proyectos asociados

Evalución del tratamiento clínico en varones con oligospermia severa, fallos de ICSI y elevada fragmentación de ADN mediante el uso de espermatozoides testiculares.

Investigador Principal: NICOLÁS GARRIDO PUCHALT

PI18/00325 . INSTITUTO DE SALUD CARLOS III . 2019

Contrato PFIS: Predoctorales de formación en investigación en salud.

Investigador Principal: NICOLÁS GARRIDO PUCHALT

FI19/00051 . INSTITUTO DE SALUD CARLOS III . 2020

Influencia del virus del papiloma humano (VPH) en semen sobre los resultados reproductivos y lavado de semen con heparinasa como opción terapéutica en la infección.

Investigador Principal: NICOLÁS GARRIDO PUCHALT

PI21/00322 . INSTITUTO DE SALUD CARLOS III . 2022

Resonancia Magnética y Biomarcadores de imagen para el mapeo, localización de focos de espermatogénesis y guiado de las biopsias testiculares en pacientes con azoospermia no obstructiva.

Investigador Principal: JOSÉ REMOHÍ GIMÉNEZ

PI21/00424 . INSTITUTO DE SALUD CARLOS III . 2022

Análisis del biomarcador epigenético en el semen involucrado en el riesgo de autismo en la descendencia.

Investigador Principal: ANA VICTORIA MARCO HERNÁNDEZ

2103-FIVI-022-NG . 2021

Influencia del virus del papiloma humano (VPH) en semen sobre los resultados reproductivos y lavado de semen con heparinasa como opción terapéutica en la infección.

Investigador Principal: NICOLÁS GARRIDO PUCHALT

CIACIF/2021/016 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2022

Identificación de biomarcadores de receptividad endometrial mediante lipidómica para mejorar los tratamientos de reproducción asistida.

Investigador Principal: NICOLÁS GARRIDO PUCHALT

FPU21/00988 . MINISTERIO DE UNIVERSIDADES . 2022

Cita

Compartir